Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment
Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90 Million Since 2021 Launch
BOSTON, Jan. 17, 2024 -- (Healthcare Sales & Marketing Network) -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite... Biopharmaceuticals, Oncology, Venture Capital Ratio Therapeutics, radiopharmaceuticals
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news